Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.
Chow E, Clement S, Garg R.
BMJ Open Diabetes Res Care. 2023 Oct;11(5):e003666. doi: 10.1136/bmjdrc-2023-003666.
Diabetic ketoacidosis.
Calimag APP, Chlebek S, Lerma EV, Chaiban JT.
Dis Mon. 2023 Mar;69(3):101418. doi: 10.1016/j.disamonth.2022.101418. Epub 2022 May 14.
Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.
Fayfman M, Pasquel FJ, Umpierrez GE.
Med Clin North Am. 2017 May;101(3):587-606. doi: 10.1016/j.mcna.2016.12.011.
Diabetic ketoacidosis.
Dhatariya KK, Glaser NS, Codner E, Umpierrez GE.
Nat Rev Dis Primers. 2020 May 14;6(1):40. doi: 10.1038/s41572-020-0165-1.
The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management.
Nyenwe EA, Kitabchi AE.
Metabolism. 2016 Apr;65(4):507-21. doi: 10.1016/j.metabol.2015.12.007. Epub 2015 Dec 19.
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB.
Diabetes Care. 2015 Sep;38(9):1687-93. doi: 10.2337/dc15-0843. Epub 2015 Jun 15.
One third of cases of new-onset diabetic ketosis in adults are associated with ketosis-prone type 2 diabetes-A systematic review and meta-analysis.
Kovacs A, Bunduc S, Veres DS, Palinkas D, Gagyi EB, Hegyi PJ, Eross B, Mihaly E, Hegyi P, Hosszufalusi N.
Diabetes Metab Res Rev. 2024 Mar;40(3):e3743. doi: 10.1002/dmrr.3743. Epub 2023 Oct 27.
Hyperosmolar Hyperglycemic State.
Stoner GD.
Am Fam Physician. 2017 Dec 1;96(11):729-736.
Management of ketosis-prone type 2 diabetes mellitus.
Smolenski S, George NM.
J Am Assoc Nurse Pract. 2019 Jul;31(7):430-436. doi: 10.1097/JXX.0000000000000183.
Euglycemic Diabetic Ketoacidosis: How Is It Different from Diabetic Ketoacidosis.
Ju HH.
Crit Care Nurs Clin North Am. 2025 Mar;37(1):157-165. doi: 10.1016/j.cnc.2024.08.004. Epub 2024 Sep 23.
